• Alibaba Health held its annual general meeting on Aug. 7, 2026 for the year ended March 31, 2026.
• Shareholders adopted the audited consolidated financial statements, directors’ report, auditor’s report; resolution passed.
• Final cash dividend was authorized at RMB 960 million, or RMB 0.0595 per share, subject to the share premium reduction becoming effective.
• Special cash dividend was authorized at RMB 2.18 billion, or RMB 0.1352 per share, subject to the share premium reduction becoming effective.
• Shareholders authorized a RMB 10 billion reduction of share premium; also adopted amendments to the company’s bye-laws.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alibaba Health Information Technology Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260807-12277546), on August 07, 2026, and is solely responsible for the information contained therein.